173 related articles for article (PubMed ID: 12629129)
1. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
[TBL] [Abstract][Full Text] [Related]
2. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Luo X; Ding L; Ripley D
Mol Cell Endocrinol; 2003 Nov; 209(1-2):9-16. PubMed ID: 14604812
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
Luo X; Xu J; Chegini N
Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
[TBL] [Abstract][Full Text] [Related]
4. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
5. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
6. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
8. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
Chegini N; Tang XM; Ma C
J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
[TBL] [Abstract][Full Text] [Related]
9. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta.
Luo X; Ding L; Xu J; Chegini N
Endocrinology; 2005 Mar; 146(3):1097-118. PubMed ID: 15604209
[TBL] [Abstract][Full Text] [Related]
11. The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta.
Luo X; Xu J; Chegini N
J Clin Endocrinol Metab; 2003 Oct; 88(10):4967-76. PubMed ID: 14557482
[TBL] [Abstract][Full Text] [Related]
12. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.
Pan Q; Luo X; Chegini N
Mol Hum Reprod; 2010 Mar; 16(3):215-27. PubMed ID: 19906824
[TBL] [Abstract][Full Text] [Related]
13. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
Chegini N; Ma C; Tang XM; Williams RS
Mol Hum Reprod; 2002 Dec; 8(12):1071-8. PubMed ID: 12468639
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
16. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.
Mori Y; Chen SJ; Varga J
Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788
[TBL] [Abstract][Full Text] [Related]
17. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
18. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
19. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
Guéripel X; Benahmed M; Gougeon A
Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
Pan Q; Luo X; Chegini N
J Cell Mol Med; 2008; 12(1):227-40. PubMed ID: 18182067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
